Trial · NCT02790463
Virtual Gout Clinic
NCT02790463, Not applicable, Completed, University of Alabama at Birmingham; results first posted 2019-11-12
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Virtual Gout Clinic. Trials, record NCT02790463. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02790463
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Virtual Gout Clinic
- NCT number
- NCT02790463
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 1,463 participants, actual
- Lead sponsor
- University of Alabama at Birmingham
- Conditions
- Gout
- Interventions
- Pharmacist-Led Intervention
- First posted
- 2016-06-03
- Last updated
- 2019-11-12
- Results first posted
- 2019-11-12
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | sUA < 6.0 mg/dl at 1 Year | 12 months | Achievement of serum uric acid (sUA) \< 6.0 mg/dl at 1 year |
| Primary | Adherence to Medication | 12 months | Adherence to prescribed medication |
Source ClinicalTrials.gov
Outcomes2
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | sUA < 6.0 mg/dl at 1 Year | 12 months | Participants | COUNT_OF_PARTICIPANTS | |
| PRIMARY | Adherence to Medication | 12 months | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.gov
Results by group4
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| sUA < 6.0 mg/dl at 1 Year | Usual Care | 117 | Participants | ||
| sUA < 6.0 mg/dl at 1 Year | Intervention | 204 | Participants | ||
| Adherence to Medication | Usual Care | 250 | Participants | ||
| Adherence to Medication | Intervention | 341 | Participants |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Usual Care | 782 | |
| Overall Study | STARTED | Intervention | 681 | |
| Overall Study | COMPLETED | Usual Care | 782 | |
| Overall Study | COMPLETED | Intervention | 372 | |
| Overall Study | NOT COMPLETED | Usual Care | 0 | |
| Overall Study | NOT COMPLETED | Intervention | 309 |
Source ClinicalTrials.gov
Adverse events4
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Toxic epidermal necolysis (TENs) | Skin and subcutaneous tissue disorders | Usual Care | 1 | 782 | 1 |
| serious | Toxic epidermal necolysis (TENs) | Skin and subcutaneous tissue disorders | Intervention | 0 | 681 | 0 |
| serious | Drug rash with eosinophilia and systemic symptoms (DRESS) | Skin and subcutaneous tissue disorders | Usual Care | 0 | 782 | 0 |
| serious | Drug rash with eosinophilia and systemic symptoms (DRESS) | Skin and subcutaneous tissue disorders | Intervention | 1 | 681 | 1 |
Source ClinicalTrials.gov
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Usual Care | 0 | 782 |
| Total, all-cause mortality | Intervention | 0 | 681 |
| Total, other adverse events | Usual Care | 0 | 782 |
| Total, other adverse events | Intervention | 0 | 681 |
| Total, serious adverse events | Usual Care | 1 | 782 |
| Total, serious adverse events | Intervention | 1 | 681 |
Source ClinicalTrials.gov
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 30503879 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons4
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|---|
| Intervention vs Usual Care: Adherence to Medication | Trial comparisons |
| Intervention vs Usual Care: deaths from any cause | Trial comparisons |
| Intervention vs Usual Care: sUA < 6.0 mg/dl at 1 Year | Trial comparisons |
| Intervention vs Usual Care: serious adverse events | Trial comparisons |
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02790463
GET https://conductscience.org/api/trials/v1/NCT02790463/registered